Jim Simons Trevi Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 70,700 shares of TRVI stock, worth $287,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,700

Previous 51,900 36.22%

Holding current value

$287,042

Previous $154,000 53.25%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.58 - $3.51 $48,504 - $65,988	18,800 Added 36.22%	70,700 $236,000
Q2 2024 Aug 09, 2024	SELL	$2.44 - $3.36 $158,458 - $218,205	-64,942 Reduced 55.58%	51,900 $154,000
Q1 2024 May 13, 2024	SELL	$1.3 - $3.7 $553,615 - $1.58 Million	-425,858 Reduced 78.47%	116,842 $403,000
Q4 2023 Feb 13, 2024	BUY	$1.06 - $2.05 $503,924 - $974,569	475,400 Added 706.39%	542,700 $727,000
Q3 2023 Nov 14, 2023	SELL	$2.11 - $2.47 $46,420 - $54,340	-22,000 Reduced 24.64%	67,300 $147,000
Q2 2023 Aug 11, 2023	SELL	$1.8 - $3.44 $266,580 - $509,464	-148,100 Reduced 62.38%	89,300 $213,000
Q1 2023 May 12, 2023	SELL	$1.69 - $2.97 $136,214 - $239,382	-80,600 Reduced 25.35%	237,400 $439,000
Q4 2022 Feb 13, 2023	SELL	$1.61 - $2.42 $162,911 - $244,872	-101,187 Reduced 24.14%	318,000 $614,000
Q3 2022 Nov 14, 2022	BUY	$1.54 - $4.28 $412,237 - $1.15 Million	267,687 Added 176.69%	419,187 $646,000
Q2 2022 Aug 12, 2022	BUY	$1.8 - $3.39 $63,900 - $120,345	35,500 Added 30.6%	151,500 $426,000
Q1 2022 May 13, 2022	SELL	$0.46 - $2.48 $101,844 - $549,072	-221,400 Reduced 65.62%	116,000 $255,000
Q4 2021 Feb 11, 2022	BUY	$0.68 - $1.5 $184,892 - $407,850	271,900 Added 415.11%	337,400 $264,000
Q3 2021 Nov 12, 2021	SELL	$1.29 - $2.18 $34,959 - $59,078	-27,100 Reduced 29.27%	65,500 $92,000
Q2 2021 Aug 13, 2021	SELL	$2.0 - $2.76 $58,498 - $80,727	-29,249 Reduced 24.0%	92,600 $208,000
Q1 2021 May 13, 2021	BUY	$2.36 - $3.55 $226,911 - $341,328	96,149 Added 374.12%	121,849 $330,000
Q4 2020 Feb 10, 2021	BUY	$2.42 - $3.99 $62,194 - $102,543	25,700 New	25,700 $62,000

Others Institutions Holding TRVI

# of Institutions

Shares Held

57.1M

Call Options Held

136K

Put Options Held

5.4K

View Full List

About Trevi Therapeutics, Inc.

Ticker TRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,322,500
Market Cap $237M
Description
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...

More about TRVI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account